Pharmacology CME for Physician Assistants
As a physician assistant, you have little time to keep up with the constantly changing drug information that you need.
Our focus is on pharmacology taught by practicing clinical pharmacists, physicians, physician assistants and doctoral level nurses to give you the specialized, evidenced based pharmacotherapeutic education you need.
Attend live physician assistant CME in fantastic destinations or earn live CME credits online from the comfort of your own home.
Don’t need live credit? We have a selection of recorded online programs on our learning management system.
Physician Assistant CME Live at Destinations
Evidence-based, non-commercial pharmacology focused live physician assistant CME.
Small class sizes and professionally acclaimed practicing clinical pharmacology educators from medical and pharmacy schools.
15 hours of live CME at a single 3 day conference offering 5 hour per day .
Morning classes give you time to enjoy the afternoon and evening at our inspiring destinations!
Stunning locations including Florida, Las Vegas, National Parks, and Hawaii as well as continuing education cruises.
Physician CME Live Online via Zoom
Evidence-based, non-commercial pharmacology focused online physician assistant CME webinars.
Live CME webinars for PA
Live online CME for physician assistants.
Physician Assistant CME Recorded Online
Evidence-based, non-commercial pharmacology focused physician assistant online CME.
3-5 hours of PA CME online recorded from University Learning Systems seminars.
Available on any mobile device via our learning management system.
Pain Management, Opioids, Diabetes CME online courses and other topics.
Accreditation and Approvals
University Learning Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. We have consistently won ACPE accreditation for over 30 years.
Live destination programs and Zoom webinars and selected recorded programs are also approved for prescribed credit by the American Academy of Family Physicians (AAFP). AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credit™ toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed credit, not as Category 1. Statements of credit earned are provided after each session.
AAFP Prescribed credit is accepted by the following organizations. Please contact them directly about how participants should report the credit they earned.
Click here for more information about our accredidation.
ULS On-Demand Courses
Generated by scrape_uls_courses_v2_category_filter.py — 40 courses
0 shown
| Title | Speaker | Category | Date | Hrs | Price | Meta |
|---|---|---|---|---|---|---|
| Dr. Joseph Saseen, Pharm.D., FASHP, FCCP, BCPS, BCACP | Cardiac | 2025-12-11 | 5 | $125 | Learn ACC/AHA hypertension guidelines, lifestyle interventions, CV risk calculators, resistant hypertension management, emerging therapies, and evidence-based prevention strategies. | |
| Dr. Christopher M. Bland | Pharm.D., FCCP, FIDSA, BCPS | Herbals | 2025-12-10 | 2 | $50 | Review common herbal supplements, FDA regulation, safety concerns, adverse effects, and clinically significant drug–herbal interactions using evidence-based resources. | |
| Dr. Christopher M. Bland | Pharm.D., FCCP, FIDSA, BCPS | Obesity | 2025-12-10 | 3 | $75 | Explore current and emerging obesity pharmacotherapy options, patient selection criteria, adverse effects, and future treatments to support effective weight management. | |
| Dr. Joseph Saseen, Pharm.D., FASHP, FCCP, BCPS, BCACP | Cardiac | 2025-12-09 | 5 | $125 | Apply ACC/AHA cholesterol guidelines, nonstatin therapies, antiplatelet strategies, and evidence-based treatments for hypercholesterolemia, CAD, PAD, and CV risk reduction. | |
| Dr. WENDY L. WRIGHT, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP | Immunization | 2025-10-15 | 2 | $50 | Review 2024 immunization schedules, vaccine benefits and side effects, and evidence-based strategies to address vaccine hesitancy across the lifespan. | |
| Dr. WENDY L. WRIGHT, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP | Patient-Safety | 2025-10-15 | 1 | $25 | Learn safe prescribing strategies, prevent drug–drug interactions, and review real malpractice cases to reduce legal risk and improve patient safety. | |
| Dr. WENDY L. WRIGHT, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP | Drug-Updates | 2025-10-13 | 2 | $50 | Review newly approved medications, updated indications, labeling changes, adverse effects, and clinically significant drug–drug interactions in this 2025 drug update course. | |
| Dr. Chelsea A. Keedy, PharmD, BCACP, CDTM | Pharmacogenomics | 2025-09-18 | 5 | $125 | 5-hour on-demand CME presented by Dr. Chelsea A. Keedy, PharmD, focusing on pharmacogenomics, personalized drug selection, drug–gene interactions, updated diabetes management guidelines with cardiovascular and renal considerations, and the use of continuous glucose monitoring to optimize therapy. Recorded September 19, 2025. | |
| Dr. Chelsea A. Keedy, PharmD, BCACP, CDTM | Womens-Health | 2025-09-17 | 5 | $125 | 5-hour on-demand CME presented by Dr. Chelsea A. Keedy, PharmD, covering women’s health and preventive medicine, including pregnancy and lactation updates, contraception, hormone replacement therapy, osteoporosis management, and RSV and pneumococcal vaccine recommendations. Recorded September 17, 2025. Valid through September 17, 2028. | |
| Dr. Randell L. Tackett, Ph.D | Addiction | 2025-08-28 | 1 | $25 | On-demand CME course on drug and alcohol withdrawal management from emergency department presentation through inpatient care and discharge planning. Recorded August 28, 2025. Valid through August 28, 2028. | |
| Dr. Joshua Caballero, Pharm.D., BCPP, FCCP | Antipsychotics | 2025-08-28 | 1 | $25 | Explore current psychopharmacology trends, including new antidepressants and antipsychotics, their off-label uses, and strategies to recognize and manage polypharmacy. Learn best practices for prescribing and monitoring psychiatric medications in primary care. | |
| Dr. Randell L. Tackett, Ph.D | Cannabinoids | 2025-08-28 | 1 | $25 | Overview of medical cannabis prescribing regulations and clinical applications, including cannabinoid pharmacokinetics, metabolism, safety considerations, and clinically significant drug–drug interactions. | |
| Dr. Joseph Saseen, Pharm.D., FASHP, FCCP, BCPS, BCACP | Cardiac | 2025-08-28 | 1 | $25 | On-demand CME course presented by Dr. Joseph Saseen, PharmD, reviewing new hypertension guidelines, first-line treatment preferences, combination therapy strategies, and evidence-based management of resistant hypertension. Recorded August 28, 2025. Valid through August 28, 2028. | |
| Dr. Sandford Levy, M.D. | Nutrition | 2025-08-28 | 1 | $25 | On-demand CME course presented by Dr. Sandford Levy, MD, examining how commonly prescribed medications contribute to drug-induced nutrient depletions and impact patient nutritional status. Recorded August 28, 2025. Valid through August 28, 2028. | |
| Dr. Chelsea A. Keedy, PharmD, BCACP, CDTM | Pharmacogenomics | 2025-08-28 | 1 | $25 | Learn how pharmacogenomics personalizes drug therapy, interprets CYP450 testing results, and improves prescribing practices for antidepressants, statins, and more. | |
| Dr. Christopher M. Bland | Pharm.D., FCCP, FIDSA, BCPS | Antimicrobials | 2025-08-27 | 2 | $50 | Learn 2025 best practices in antimicrobial stewardship, including appropriate prescribing during transitions of care and in outpatient settings, updates on newly approved antibiotics and new indications, and evidence-based strategies for assessing and de-labeling self-reported penicillin allergy. | |
| Dr. Anna Paritsky DMD, DDS | Dental | 2025-08-27 | 4 | $95 | Review American Heart Association and American Dental Association guidelines on dental antibiotic prophylaxis, including which cardiac patients need prophylaxis, which dental procedures require it, and recommended antibiotics and dosages. | |
| Dr. Dr. Kajal Jain, Pharm.D | Immunotherapy | 2025-08-27 | 4 | $95 | Overview of monoclonal antibody medications used to treat psoriasis, rheumatoid arthritis, and asthma, including indications, required safety monitoring, adverse effects, and essential patient education for safe and effective therapy. | |
| Dr. Stacey Hollen PharmD, BCACP | Pain | 2025-08-27 | 4 | $95 | Summary of the 2022 CDC Opioid Prescribing Guideline focusing on safe opioid use, nonopioid pain treatments, risk mitigation, buprenorphine alternatives, and evidence-based management of acute and chronic pain conditions. | |
| Cory Jenks PharmD, BCPS, BCACP | Diabetes | 2025-06-11 | 5 | $125 | Learn how hyperinsulinemia and insulin resistance drive the development of type 2 diabetes and how these mechanisms influence diabetes medication choices. Explore evidence supporting Therapeutic Carbohydrate Restriction (TCR), understand best practices for combining lifestyle and medication interventions, and apply critical thinking and evidence-based medicine tools to personalize treatment for patients with T2D. | |
| Dr. Gregory L. Holmquist, PharmD, CPE | Pain | 2025-06-10 | 5 | $125 | 1. Define what “palliative care” is 2. State common symptoms experienced by palliative care patients 3. Compare and contrast core pharmacological principles 4. Describe best practice for use of common pain medications 5. Propose a pharmacological management strategy for each of the following symptoms: 6. Cite four general principles for medication optimization | |
| Dr. C. Wayne Weart | Pharm.D., BCPS, FASHP | Drug-Updates | 2025-04-24 | 10 | $200 | Experience an Exceptional New Drug Update from Patient Outcomes Dr. C. Wayne Weart is an nationally known expert on new drugs and how they compare to existing medications. Dr. Weart helps you to understand the decisions behind the studies that lead to the evidence in the approval process. | |
| Dr. Reamer L. Bushardt, PharmD, PA-C, DFAAPA | Depression | 2025-02-20 | 3 | $75 | Review evidence-based management of depression, anxiety, and sleep disorders, including off-label mood stabilizer use, guideline-driven therapy, and safe prescribing in primary care. | |
| Dr. Reamer L. Bushardt, PharmD, PA-C, DFAAPA | Renal | 2025-02-19 | 2 | $50 | Review evidence-based strategies for managing osteoporosis in patients with chronic kidney disease. Earn 2 CME hours with this on-demand course by Dr. Reamer L. Bushardt, PharmD, PA-C. | |
| Avoiding Drug Injury in Older Adult & | Opiods | 2025-02-18 | $75 | Explore aging-related pharmacologic changes, polypharmacy tools, high-risk interactions, and evolving U.S. opioid-prescribing guidelines with regulatory best practices. | ||
| Dr. Christopher M. Bland | Pharm.D., FCCP, FIDSA, BCPS | Antimicrobials | 2024-12-13 | 5 | $125 | Review antimicrobial safety in older adults, migraine management including CGRP inhibitors, and evidence-based obesity pharmacotherapy with GLP-1 and GIP agents through case-based learning. | |
| Dr. Gregory L. Holmquist, PharmD, CPE | Pain | 2024-12-12 | 5 | $125 | Learn opioid misuse impact, pain management fundamentals, drug mechanisms, benefits vs. risks, safe monitoring, interactions, and naloxone counseling best practices. | |
| Dr. WENDY L. WRIGHT, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP | Drug-Updates | 2024-10-09 | 3 | $75 | Review newly approved medications, updated labeling and indications, adverse effects, and clinically important drug–drug interactions in this comprehensive 2024 drug update course. | |
| Dr. Jennifer M. Trujillo, PharmD, BCPS, CDE, BC-ADM | Diabetes | 2024-09-18 | 5 | $125 | Learn diabetes therapy updates with a focus on cardiovascular risk reduction, hypertension management, and evidence-based prevention strategie | |
| Dr. Andrea Sikora Pharm.D., MSCR, FCCM, BCCCP | Acute-Care | 2024-08-29 | 1 | $25 | Learn evidence-based approaches for treating anaphylaxis in primary and acute care settings. Develop effective acute seizure management plans and identify common adverse effects of widely used anti-epileptic medications. | |
| Dr. Joshua Caballero, Pharm.D., BCPP, FCCP | Antipsychotics | 2024-08-29 | 2 | $50 | A focused 2-hour session with Dr. Caballero covering evidence-based treatment approaches for Alzheimer’s disease, depression, and adult-onset ADHD/ADD. Learn current pharmacologic strategies, diagnostic considerations, and best practices for managing cognitive decline and mood disorders in adults. | |
| Dr. Peter S. Buch, MD, AGAF, FACP | Gastronintestinal | 2024-08-29 | 4 | $95 | Gain evidence-based training in gastroenterology with modules on IBS, IBD, NAFLD/NASH, Celiac Disease, GERD, Barrett’s, probiotics, C. difficile, H. pylori, abdominal pain, colon cancer screening, diarrhea, constipation, GI bleeding, and diverticulitis. | |
| Dr. Sheryl (Follin) Vondracek, Pharm.D., FCCP, BCPS | Renal | 2024-08-29 | 2 | $50 | Concise, clinician-focused guide to SGLT2 inhibitors, GLP-1 RAs, finerenone, hyperkalemia therapies, anemia management (iron & ESAs), and CKD-MBD treatments. Includes mechanisms, roles, pros/cons, and quick selection tips. | |
| Dr. Sheryl (Follin) Vondracek, Pharm.D., FCCP, BCPS | Renal | 2024-08-29 | 5 | $125 | Learn key mechanisms, roles, pros and cons, and management strategies for CKD therapies including SGLT2 inhibitors, finerenone, loop/thiazide diuretics, hyperkalemia treatments, anemia therapy, CKD-MBD management, and emerging IgA nephropathy drugs. | |
| Dr. C. Wayne Weart | Pharm.D., BCPS, FASHP | Diabetes | 2024-08-28 | 2 | $50 | Learn the 2024 ADA Standards of Care and the evidence behind them. Apply landmark diabetes trial data showing how improved glycemic control reduces complications in type 2 diabetes. Understand the modern shift from A1C-only treatment to an outcome-based approach focused on reducing cardiovascular, heart failure, kidney disease, and obesity risks—especially in older adults with comorbidities. | |
| Dr. Christopher M. Bland Pharm.D., FCCP, FIDSA, BCPS | Nutrition | 2024-08-28 | 1 | $25 | On-demand CME course reviewing migraine pharmacotherapy, including older treatment strategies, newer agents such as botulinum toxin (Botox), and best practices through case-based applications | |
| Reamer L. Bushardt, PharmD, PA-C, DFAAPA | Opiods | 2024-06-05 | 5 | $125 | Learn safe controlled substance prescribing, age-related pharmacologic changes, polypharmacy management, depression treatment, and substance use disorder care through case-based sessions. | |
| Reamer L. Bushardt, PharmD, PA-C, DFAAPA | Opiods | 2024-06-04 | 5 | $125 | Focus on safe controlled substance prescribing, opioid risk reduction, age-sensitive dosing, polypharmacy management, and substance use disorder treatment in clinical practice. | |
| Dr. Peter S. Buch, MD, AGAF, FACP | Gastronintestinal | 2024-02-27 | 15 | $225 | Enhance your GI expertise with evidence-based CME sessions on IBS, IBD, NAFLD/NASH, Celiac Disease, GERD, probiotics, H. pylori, colon cancer screening, chronic diarrhea, constipation, GI bleeding, and diverticular disease. Practical tools for diagnosis and treatment. | |
| Dr. Reamer L. Bushardt, PharmD, PA-C, DFAAPA | Opiods | 2024-01-09 | 10 | Comprehensive CME course on safe prescribing and addiction medicine. Session 1 focuses on opioid prescribing best practices, regulatory compliance, and preventing drug injury in older adults. Session 2 explores addiction neuroscience, harm reduction, and SBIRT screening tools. Session 3 covers evidence-based treatments for substance use disorders, pharmacotherapy, ASAM criteria, and patient engagement strategies. Ideal for clinicians managing pain, addiction, and controlled substance therapy. |